Jacobs Levy Equity Management, Inc Ultragenyx Pharmaceutical Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 97,960 shares of RARE stock, worth $4.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

97,960

Previous 634,327 84.56%

Holding current value

$4.67 Million

Previous $26.1 Million 79.13%

% of portfolio

0.02%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $21.6 Million - $31.8 Million	-536,367 Reduced 84.56%	97,960 $5.44 Million
Q2 2024 Aug 14, 2024	SELL	$37.42 - $51.61 $1.99 Million - $2.75 Million	-53,292 Reduced 7.75%	634,327 $26.1 Million
Q1 2024 May 15, 2024	SELL	$43.02 - $53.69 $1.35 Million - $1.68 Million	-31,359 Reduced 4.36%	687,619 $32.1 Million
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $929,689 - $1.44 Million	-29,300 Reduced 3.92%	718,978 $34.4 Million
Q3 2023 Nov 16, 2023	BUY	$34.92 - $46.66 $5.03 Million - $6.72 Million	143,991 Added 23.83%	748,278 $26.7 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $6.41 Million - $8.94 Million	-171,488 Reduced 22.11%	604,287 $27.9 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $4.24 Million - $5.59 Million	114,692 Added 17.35%	775,775 $31.1 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $14.8 Million - $20.4 Million	440,203 Added 199.3%	661,083 $30.6 Million
Q3 2022 Nov 15, 2022	BUY	$39.96 - $66.14 $8.83 Million - $14.6 Million	220,880 New	220,880 $9.15 Million
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $178,887 - $242,734	-2,876 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $211,989 - $252,685	2,876 New	2,876 $242,000
Q4 2020 Feb 16, 2021	SELL	$84.4 - $177.39 $1 Million - $2.11 Million	-11,898 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $1.09 Million - $1.34 Million	-14,908 Reduced 55.61%	11,898 $978,000
Q2 2020 Aug 17, 2020	BUY	$46.91 - $78.22 $798,830 - $1.33 Million	17,029 Added 174.17%	26,806 $2.1 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $330,462 - $614,973	9,777 New	9,777 $434,000
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $229,594 - $403,516	-4,730 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $209,680 - $276,799	4,730 New	4,730 $241,000

Others Institutions Holding RARE

# of Institutions

322

Shares Held

85.5M

Call Options Held

668K

Put Options Held

288K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.34B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Ultragenyx Pharmaceutical Inc. Transaction History